Literature DB >> 6928611

Thermal stability of type I and type III procollagens from normal human fibroblasts and from a patient with osteogenesis imperfecta.

L Peltonen, A Palotie, T Hayashi, D J Prockop.   

Abstract

Type I and type III procollagens were isolated from the medium of human fibroblast cultures in amounts adequate for examination by circular dichroism. Type I procollagen had a spectrum similar to that of type I procollagen and collagen from chicken embryos. The human type III procollagen showed a red shift not seen in type III collagen from calf skin. The midpoint (tm) for the helix-to-coil transition for both human procollagens was 40 degrees C. the same tm values were obtained with type I and type III procollagens synthesized by fibroblasts from a patient with osteogenesis imperfecta. Type I procollagen synthesized by the patient's fibroblasts, however, tended to aggregate more readily than type I procollagen from normal human fibroblasts, apparently because of a structural alteration of the protein.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6928611      PMCID: PMC348228          DOI: 10.1073/pnas.77.1.162

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Isolation, chemical and electron microscopical characterization of neutral-salt-soluble type III collagen and procollagen from fetal bovine skin.

Authors:  R Timpl; R W Glanville; H Nowack; H Wiedemann; P P Fietzek; K Kühn
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1975-11

2.  Characterization of type III procollagen from chick embryo blood vessels.

Authors:  L I Fessler; J H Fessler
Journal:  J Biol Chem       Date:  1979-01-10       Impact factor: 5.157

3.  Collagen fibrillogenesis: intermediate aggregates and suprafibrillar order.

Authors:  R L Trelstad; K Hayashi; J Gross
Journal:  Proc Natl Acad Sci U S A       Date:  1976-11       Impact factor: 11.205

4.  The biosynthesis of collagen and its disorders (first of two parts).

Authors:  D J Prockop; K I Kivirikko; L Tuderman; N A Guzman
Journal:  N Engl J Med       Date:  1979-07-05       Impact factor: 91.245

5.  The renaturation of soluble collagen. Products formed at different temperatures.

Authors:  G Beier; J Engel
Journal:  Biochemistry       Date:  1966-08       Impact factor: 3.162

6.  Thermal stability of the triple helix of type I procollagen and collagen. Precautions for minimizing ultraviolet damage to proteins during circular dichroism studies.

Authors:  T Hyashi; S Curran-Patel; D J Prockop
Journal:  Biochemistry       Date:  1979-09-18       Impact factor: 3.162

7.  Procollagen segment-long-spacing crystallites: their role in collagen fibrillogenesis.

Authors:  R R Bruns; D J Hulmes; S F Therrien; J Gross
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

8.  Three conformationally distinct domains in the amino-terminal segment of type III procollagen and its rapid triple helix leads to and comes from coil transition.

Authors:  P Bruckner; H P Bächinger; R Timpl; J Engel
Journal:  Eur J Biochem       Date:  1978-10-16

9.  The nature of the collagen synthesized by cultured human fibroblasts.

Authors:  D L Layman; E B McGoodwin; G R Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1971-02       Impact factor: 11.205

10.  Partial purification and characterization of a neutral protease which cleaves the N-terminal propeptides from procollagen.

Authors:  L Tuderman; K I Kivirikko; D J Prockop
Journal:  Biochemistry       Date:  1978-07-25       Impact factor: 3.162

View more
  15 in total

1.  Substitution of aspartate for glycine 1018 in the type III procollagen (COL3A1) gene causes type IV Ehlers-Danlos syndrome: the mutated allele is present in most blood leukocytes of the asymptomatic and mosaic mother.

Authors:  S Kontusaari; G Tromp; H Kuivaniemi; C Stolle; F M Pope; D J Prockop
Journal:  Am J Hum Genet       Date:  1992-09       Impact factor: 11.025

2.  Thermal stability of human-fibroblast-collagenase-cleavage products of type-I and type-III collagens.

Authors:  C C Danielsen
Journal:  Biochem J       Date:  1987-11-01       Impact factor: 3.857

3.  Circular Dichroism Spectroscopy of Collagen Fibrillogenesis: A New Use for an Old Technique.

Authors:  Kathryn E Drzewiecki; Daniel R Grisham; Avanish S Parmar; Vikas Nanda; David I Shreiber
Journal:  Biophys J       Date:  2016-12-06       Impact factor: 4.033

4.  Structure of a full-length cDNA clone for the prepro alpha 2(I) chain of human type I procollagen. Comparison with the chicken gene confirms unusual patterns of gene conservation.

Authors:  H Kuivaniemi; G Tromp; M L Chu; D J Prockop
Journal:  Biochem J       Date:  1988-06-15       Impact factor: 3.857

5.  Osteogenesis imperfecta type IV. Biochemical confirmation of genetic linkage to the pro alpha 2(I) gene of type I collagen.

Authors:  R J Wenstrup; P Tsipouras; P H Byers
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

6.  Synthesis of recombinant human procollagen II in a stably transfected tumour cell line (HT1080).

Authors:  A Fertala; A L Sieron; A Ganguly; S W Li; L Ala-Kokko; K R Anumula; D J Prockop
Journal:  Biochem J       Date:  1994-02-15       Impact factor: 3.857

7.  Analysis of cyanogen bromide peptides of type I collagen from a patient with lethal osteogenesis imperfecta.

Authors:  E Kirsch; R W Glanville; T Krieg; P Müller
Journal:  Biochem J       Date:  1983-06-01       Impact factor: 3.857

8.  Osteogenesis imperfecta: a heterogeneous morphologic phenotype in cultured dermal fibroblasts.

Authors:  A P Boright; G A Lancaster; C R Scriver
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

9.  Inherited abnormalities of collagen.

Authors:  F M Pope
Journal:  J Med Genet       Date:  1981-04       Impact factor: 6.318

10.  Fulvic acid supplementation and selenium deficiency disturb the structural integrity of mouse skeletal tissue. An animal model to study the molecular defects of Kashin-Beck disease.

Authors:  C Yang; C Niu; M Bodo; E Gabriel; H Notbohm; E Wolf; P K Müller
Journal:  Biochem J       Date:  1993-02-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.